NCT01500720 - Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer | Biotech Hunter

Enrollment

179

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Small Cell Lung Cancer

Interventions

DRUG

Cabazitaxel

Cabazitaxel 25 milligram per square meter (mg/m\^2) intravenously (IV) on Day 1 every 3 weeks (21-day cycle) until unacceptable toxicity, disease progression or withdrawal consent.

DRUG

Topotecan

Topotecan 1.5 mg/m\^2 IV on Day 1 to Day 5 every 3 weeks (21-Day cycle) until unacceptable toxicity, disease progression or withdrawal consent.

Trial Locations (58)

1121

Investigational Site Number 348001, Budapest

Investigational Site Number 348004, Budapest

1125

Investigational Site Number 348002, Budapest

2045

Investigational Site Number 348003, Törökbálint

4011

Investigational Site Number 578003, Stavanger

7006

Investigational Site Number 578002, Trondheim

11522

Investigational Site Number 300005, Athens

11527

Investigational Site Number 300003, Athens

14033

Investigational Site Number 250004, Caen

16132

Investigational Site Number 380001, Genova

19104

Investigational Site Number 840001, Philadelphia

22927

Investigational Site Number 276003, Großhansdorf

28100

Investigational Site Number 380005, Novara

29010

Investigational Site Number 724005, Málaga

29609

Investigational Site Number 250005, Brest

35661

Investigational Site Number 840007, Muscle Shoals

38700

Investigational Site Number 250006, La Tronche

43100

Investigational Site Number 380004, Parma

44805

Investigational Site Number 250003, Saint-Herblain

45042

Investigational Site Number 840003, Middletown

46026

Investigational Site Number 724001, Valencia

49102

Investigational Site Number 804002, Dnipropetrovsk

54629

Investigational Site Number 300002, Thessaloniki

57010

Investigational Site Number 300004, Thessaloniki

57123

Investigational Site Number 380002, Livorno

59800

Investigational Site Number 250002, Lille

68114

Investigational Site Number 840005, Omaha

70031

Investigational Site Number 804001, Lviv

71110

Investigational Site Number 300001, Heraklion

74245

Investigational Site Number 276006, Löwenstein

83092

Investigational Site Number 804004, Donetsk

94805

Investigational Site Number 250007, Villejuif

115478

Investigational Site Number 643001, Moscow

150054

Investigational Site Number 643003, Yaroslavl

197758

Investigational Site Number 643005, Saint Petersburg

200385

Investigational Site Number 642001, Craiova

300053

Investigational Site Number 643006, Tula

400015

Investigational Site Number 642003, Cluj-Napoca

Investigational Site Number 642005, Cluj-Napoca

8380456

Investigational Site Number 152001, Santiago

03756

Investigational Site Number 840006, Lebanon

90610-000

Investigational Site Number 076001, Porto Alegre

H3T 1E2

Investigational Site Number 124003, Montreal

L1G 2B9

Investigational Site Number 124002, Oshawa

G5L 5T1

Investigational Site Number 124004, Rimouski

M5G 2M9

Investigational Site Number 124001, Toronto

Unknown

Investigational Site Number 152005, Santiago

Investigational Site Number 642002, Timișoara

0440

Investigational Site Number 578001, Oslo

80-952

Investigational Site Number 616004, Gdansk

20-954

Investigational Site Number 616003, Lublin

60-569

Investigational Site Number 616002, Poznan

02-781

Investigational Site Number 616001, Warsaw

120-752

Investigational Site Number 410001, Seoul

135-710

Investigational Site Number 410003, Seoul

138-736

Investigational Site Number 410002, Seoul

08916

Investigational Site Number 724002, Badalona

08035

Investigational Site Number 724004, Barcelona